The nervous system medicine market in Canada is forecasted to grow steadily from CAD 8.14 billion in 2024 to CAD 10.22 billion in 2028. This represents a compound annual growth rate (CAGR) of approximately 5.8%. The year-on-year growth rate is consistent, with an average increase of about 5% annually. Sales in 2023 were slightly lower than CAD 8.14 billion, marking a substantive upward trend in the sector.
Future trends to watch for include:
- Innovation in treatment options and technological advancements.
- Increased prevalence of neurological disorders boosting demand.
- Regulatory changes and their impact on market dynamics.
- Emergence of biosimilars as cost-effective alternatives.
